Genomics

Dataset Information

0

Specific serum methylome of the serrated pathway of colorectal carcinogenesis


ABSTRACT: This study was conducted to explore the serum methylome of precancerous lesions belonging to the serrated pathway of colorectal carcinogenesis in a prospective multicentre cohort. Individuals were grouped into five main categories: (i) serrated adenocarcinoma (SAC), (ii) high-risk serrated polyps (HR-SP) comprising traditional serrated adenomas (TSA), sessile serrated lesions (SSL), and serrated polyps (SP) with dysplasia or ≥ 10 mm; (iii) high-risk hyperplastic polyps (HR-HP), defined as HP ≥ 10 mm; (iv) low-risk serrated lesions (LR-SL) including SP without dysplasia < 10 mm and HP < 10 mm; and (v) healthy individuals with no colorectal findings (NCF). First, epigenome-wide methylation levels were quantified in pooled cfDNA samples to characterize the differential methylation profile between no serrated neoplasia (NSN: NCF and LR-SL) and high-risk serrated lesions (HR-SL: HR-HP and HR-SP); concordance with tissue methylation levels was assessed using external datasets. Then, the pathway-specific cfDNA methylation signature was evaluated together with cfDNA pools from the conventional CRC pathway. cfDNA was extracted from serum samples and methylation measurements were assessed with the Infinium MethylationEPIC BeadChip. Data was mainly preprocessed and analyzed with R/Bioconductor packages.

ORGANISM(S): Homo sapiens

PROVIDER: GSE199173 | GEO | 2024/03/01

REPOSITORIES: GEO

Similar Datasets

2014-02-12 | E-GEOD-47735 | biostudies-arrayexpress
2014-02-12 | E-GEOD-47734 | biostudies-arrayexpress
2008-08-27 | GSE12514 | GEO
2015-09-29 | GSE73487 | GEO
2014-02-12 | GSE47735 | GEO
2014-02-12 | GSE47734 | GEO
2018-10-18 | GSE118504 | GEO
2008-08-26 | E-GEOD-12514 | biostudies-arrayexpress
2018-12-19 | GSE108317 | GEO
2016-04-08 | GSE76987 | GEO